Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Heller

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Expert Opinion on Pharmacotherapy|February 7, 2002
Insulin aspart: promising early results borne out in clinical practiceSimon Heller, Peter Kurtzhals, Danilo Verge, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 16, 2025
The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetesSimon A Berry, Iona Goodman, Simon Heller, et al.
Journal of Diabetes|April 17, 2013
Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitusSimon Heller, Bruce Bode, Plamen Kozlovski, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 31, 2018
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approachRichard F Pollock, Barrie Chubb, William J Valentine, et al.
Journal of Health Services Research & Policy|April 5, 2011
Organizing and delivering diabetes education and self-care support: findings of scoping projectAngus Forbes, Alison While, Peter Griffiths, et al.
British Journal of Health Psychology|January 6, 2015
Efficacy of theory-based interventions for young people with type 1 diabetes: a systematic review and meta-analysisKieran Ayling, Samantha Brierley, Barbara Johnson, et al.
Sociology of Health & Illness|April 11, 2019
Disruptive illness contexts and liminality in the accounts of young people with type 1 diabetesTom Sanders, Jackie Elliott, Paul Norman, et al.
Frontiers in Systems Neuroscience|October 9, 2018
A Comparison of Machine Learning Classifiers for Energy-Efficient Implementation of Seizure DetectionFarrokh Manzouri, Simon Heller, Matthias Dümpelmann, et al.
Seizure|March 10, 2026
Polysubstance overdose with cenobamate, levetiracetam and clobazam: Insights into cenobamate toxicityAdam Carter, Amy E Edwards, Lina Nashef, et al.
Diabetes/Metabolism Research and Reviews|June 23, 2011
Diversity in diabetes: the role of insulin aspartSimon Heller, David R McCance, Etie Moghissi, et al.
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|February 7, 2002
Insulin aspart: promising early results borne out in clinical practiceSimon Heller, Peter Kurtzhals, Danilo Verge, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 16, 2025
The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetesSimon A Berry, Iona Goodman, Simon Heller, et al.
Journal of Diabetes|April 17, 2013
Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitusSimon Heller, Bruce Bode, Plamen Kozlovski, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 31, 2018
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approachRichard F Pollock, Barrie Chubb, William J Valentine, et al.
Journal of Health Services Research & Policy|April 5, 2011
Organizing and delivering diabetes education and self-care support: findings of scoping projectAngus Forbes, Alison While, Peter Griffiths, et al.
British Journal of Health Psychology|January 6, 2015
Efficacy of theory-based interventions for young people with type 1 diabetes: a systematic review and meta-analysisKieran Ayling, Samantha Brierley, Barbara Johnson, et al.
Sociology of Health & Illness|April 11, 2019
Disruptive illness contexts and liminality in the accounts of young people with type 1 diabetesTom Sanders, Jackie Elliott, Paul Norman, et al.
Frontiers in Systems Neuroscience|October 9, 2018
A Comparison of Machine Learning Classifiers for Energy-Efficient Implementation of Seizure DetectionFarrokh Manzouri, Simon Heller, Matthias Dümpelmann, et al.
Seizure|March 10, 2026
Polysubstance overdose with cenobamate, levetiracetam and clobazam: Insights into cenobamate toxicityAdam Carter, Amy E Edwards, Lina Nashef, et al.
Diabetes/Metabolism Research and Reviews|June 23, 2011
Diversity in diabetes: the role of insulin aspartSimon Heller, David R McCance, Etie Moghissi, et al.
Pageof 16